MedTrace Logo

Using mHealth to Modernize Diabetes Care

NCT03516474 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-05-04

No results posted yet for this study

Summary

In this study the investigators are testing a device that may help us tell how well the participants' wound is healing. This device is called the MIMOSA, and it shines different "colours" of light on the participants' skin. It will not touch the participants' skin, or change how the participants' wound is healing. The MIMOSA is designed to be used alongside the camera that is built into the participants' cell phone, and the investigators will use a cell phone to take a picture of the participants' skin. This picture will tell us how much oxygen is getting to the participants' wound, which can tell us more about how the participants are healing. The MIMOSA device is an experimental diagnostic tool, and will not influence how the participants' wound is healing.

Conditions

  • Diabetic Foot

Interventions

DEVICE

MIMOSA Diagnostics

The MIMOSA shines different "colours" of light on your skin. It will not touch your skin, or change how your wound is healing. The MIMOSA is designed to be used alongside the camera that is built into your cell phone, and we will use a cell phone to take a picture of your skin. This picture will tell us how much oxygen is getting to your wound, which can tell us more about how you are healing. The MIMOSA device is an experimental diagnostic tool, and will not influence how your wound is healing.

Sponsors & Collaborators

  • South Riverdale Community Health Centre

    collaborator UNKNOWN

  • West Park Healthcare Centre

    collaborator OTHER

  • Women's College Hospital

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03516474 on ClinicalTrials.gov